Picture of Privia Health logo

PRVA — Privia Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Privia Health Q2 revenue beats estimates, outlook raised

Privia Health Q2 revenue beats estimates, outlook raised


Overview

  • U.S. physician enablement firm's Q2 revenue rose 21% yr/yr, beating analyst expectations

  • Company raised full-year 2026 guidance for all key financial metrics


Outlook

  • Privia Health raises full-year 2026 guidance for all key financial metrics

  • Company now sees 2026 revenue at $2.45 bln, the high end of prior range

  • Company expects 2026 adjusted EBITDA at $155 mln, mid to high end of range


Result Drivers

  • PROVIDER NETWORK EXPANSION - Number of implemented providers grew 10% yr/yr, supporting revenue and operational gains

  • ATTRIBUTED LIVES GROWTH - Attributed lives under value-based care arrangements increased 19% yr/yr

  • PRACTICE COLLECTIONS INCREASE - Practice collections rose 12% yr/yr, reflecting higher patient volumes and service delivery


Company press release: ID:nGNXbSNTJ6


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$632.60 mln

$598.84 mln (17 Analysts)

Q2 EPS

$0.07

Q2 Net Income

$9 mln

Q2 Operating Income

$11.80 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Privia Health Group Inc is $31.00, about 29.4% above its August 5 closing price of $23.96

  • The stock recently traded at 70 times the next 12-month earnings vs. a P/E of 61 three months ago


Reuters Recommended Reads

  • Aug 5 - Agilon Health Q2 revenue beats estimates, raises outlook

  • Aug 5 - Clover Health Q2 revenue rises 56%, beating estimates on memership growth

  • Aug 4 - Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Privia Health

See all news